Nephrogenic diabetes insipidus tertiary prevention: Difference between revisions
Created page with "__NOTOC__ {{Nephrogenic diabetes insipidus}} {{CMG}}; '''Associate Editor in Chief:''' {{CZ}} Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_..." |
|||
(One intermediate revision by the same user not shown) | |||
Line 9: | Line 9: | ||
==Tertiary Prevention== | ==Tertiary Prevention== | ||
Prevention or reduction of serious renal, ureteral, or bladder dilatation may be achieved by reduction of urine production by drug therapy and voiding at two-hour intervals. | Prevention or reduction of serious renal, ureteral, or bladder dilatation may be achieved by reduction of urine production by drug therapy and voiding at two-hour intervals. | ||
Restriction of water intake. | |||
==References== | ==References== |
Latest revision as of 04:25, 21 September 2012
Nephrogenic diabetes insipidus Microchapters |
Differentiating Nephrogenic diabetes insipidus from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nephrogenic diabetes insipidus tertiary prevention On the Web |
American Roentgen Ray Society Images of Nephrogenic diabetes insipidus tertiary prevention |
Nephrogenic diabetes insipidus tertiary prevention in the news |
Directions to Hospitals Treating Nephrogenic diabetes insipidus |
Risk calculators and risk factors for Nephrogenic diabetes insipidus tertiary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor in Chief: Cafer Zorkun, M.D., Ph.D. [2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Tertiary Prevention
Prevention or reduction of serious renal, ureteral, or bladder dilatation may be achieved by reduction of urine production by drug therapy and voiding at two-hour intervals.
Restriction of water intake.